Can an ultrasound spot diabetes risk? new study investigates pancreatic fat

NCT ID NCT07155473

Recruiting now Knowledge-focused Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study aims to understand how fat buildup in the pancreas (pancreatic steatosis) is linked to type 2 diabetes and metabolic syndrome. Researchers will use a special ultrasound technique to measure pancreatic fat and compare it with blood sugar and other metabolic tests. 100 adults undergoing endoscopy will participate. The goal is to develop a scoring system that could help identify people at higher risk for diabetes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a simple ultrasound score to help predict a person's risk of developing type 2 diabetes.
What could go wrong: This is an early, small study (100 people) that only looks for links, not treatments. The findings may not apply to everyone and need further validation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

abdominal obesity-metabolic syndrome diabetes mellitus metabolic syndrome X type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES METABOLIC SYNDROME X PANCREATIC STEATOSIS

Contacts and locations

Locations

Gemelli University Hospital
RECRUITING

Roma, Rome, 00168, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.